Tourmaline Bio, Inc.
TRMLDelisted Oct 28, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001827506
Tourmaline Bio, Inc. was delisted on Oct 28, 2025; its insiders filed their last Form 4 on Oct 28, 2025; 134 institutions reported holding it in 13F filings for Q3 2025, worth $1.03B in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding Tourmaline Bio, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 50 | 48 | −2 |
| Shares | 26.0M | 25.9M | −106.7K (−0.4%) |
| Value | $379.4M | $349.4M | −$30.0M (−7.9%) |
New holders (5)
Institutions that held Tourmaline Bio, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Healthcare of Ontario Pension Plan Trust Fund | 76,800 | $1.04M | 0.00% |
| Parametric Portfolio Associates LLC | 16,934 | $230.0K | 0.00% |
| State of Wisconsin Investment Board | 11,500 | $156.0K | 0.00% |
| Captrust Financial Advisors | 198 | $3.00K | 0.00% |
| TCI Wealth Advisors, Inc. | 60 | $1.00K | 0.00% |
Sold out (7)
Institutions that held Tourmaline Bio, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Alyeska Investment Group, L.P. | 50,000 | $735.0K |
| Clough Capital Partners L P | 33,600 | $494.0K |
| Monashee Investment Management LLC | 25,000 | $367.0K |
| Zimmer Partners, LP | 23,331 | $343.0K |
| Cubist Systematic Strategies, LLC | 9,920 | $146.0K |
| Point72 Hong Kong Ltd | 675 | $10.0K |
| First Horizon Advisors, Inc. | 250 | $4.00K |